Loading organizations...
MDS Capital Corp. is a venture capital firm investing in early to late-stage health and life science companies. It provides capital and strategic guidance to innovative enterprises developing new therapies, medical devices, and diagnostics. The firm aims to foster growth in companies dedicated to advancing human health and scientific discovery.
Established in 1988 by MDS Inc., a global health and life sciences company, MDS Capital Corp. was formed with the insight that dedicated venture capital would accelerate commercialization of groundbreaking biotechnologies. This initiative recognized the specialized expertise and capital needed to transform complex scientific innovations into viable market solutions, positioning the firm as a focused industry investor.
MDS Capital Corp. partners with burgeoning companies and entrepreneurs within the health and life science ecosystem. The firm’s vision centers on cultivating a robust portfolio of companies achieving commercial success while significantly contributing to improving global health outcomes and pushing scientific boundaries.
MDS Capital has 1 tracked investment across 1 company. The latest tracked deal is $10.1M Other Equity in PhageTech in March 2002.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 15, 2002 | PhageTech | $10.1M Other Equity | CDP Capital Technology Ventures | Genechem, Seaflower Ventures, T2c2/bio |